Literature DB >> 12490963

The immunopathogenesis of sepsis.

Jonathan Cohen1.   

Abstract

Sepsis is a condition that results from a harmful or damaging host response to infection. Many of the components of the innate immune response that are normally concerned with host defences against infection can, under some circumstances, cause cell and tissue damage and hence multiple organ failure, the clinical hallmark of sepsis. Because of the high mortality of sepsis in the face of standard treatment, many efforts have been made to improve understanding of the dysregulation of the host response in sepsis. As a result, much has been learnt of the basic principles governing bacterial-host interactions, and new opportunities for therapeutic intervention have been revealed.

Entities:  

Mesh:

Year:  2002        PMID: 12490963     DOI: 10.1038/nature01326

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  811 in total

1.  Increased Resistin Levels in Intra-abdominal Sepsis: Correlation with proinflammatory cytokines and Acute Physiology and Chronic Health Evaluation (APACHE) II scores.

Authors:  Tonguç U Yilmaz; Mustafa Kerem; Canan Y Demirtaş; Ozge Pasaoǧlu; Oge Taşcilar; Omer Sakrak; Kürşat Dikmen; Tarkan Karahan
Journal:  Sultan Qaboos Univ Med J       Date:  2014-10-14

2.  Cynandione A attenuates lipopolysaccharide-induced production of inflammatory mediators via MAPK inhibition and NF-κB inactivation in RAW264.7 macrophages and protects mice against endotoxin shock.

Authors:  Sung Hwan Kim; Tae Hoon Lee; Sang Min Lee; Ji Hae Park; Keun Hyung Park; Mira Jung; Hana Jung; Mohamed Antar Aziz Mohamed; Nam-In Baek; In Sik Chung; Jiyoung Kim
Journal:  Exp Biol Med (Maywood)       Date:  2014-10-30

3.  Caveolin-1 protects against sepsis by modulating inflammatory response, alleviating bacterial burden, and suppressing thymocyte apoptosis.

Authors:  Hong Feng; Ling Guo; Zhiqing Song; Haiqing Gao; Dan Wang; Weisi Fu; Jingyan Han; Zhenyu Li; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

4.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

5.  Glycyrrhizic Acid Prevents Sepsis-Induced Acute Lung Injury and Mortality in Rats.

Authors:  Hongyu Zhao; Min Zhao; Yu Wang; Fengchun Li; Zhigang Zhang
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

6.  Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.

Authors:  Zenggeng Wang; Qinghua Wu; Xiangbi Nie; Jinghua Guo; Chunli Yang
Journal:  Clin Drug Investig       Date:  2015-11       Impact factor: 2.859

7.  Anti-inflammatory effects of hyperoside in human endothelial cells and in mice.

Authors:  Sae-Kwang Ku; Wei Zhou; Wonhwa Lee; Min-Su Han; MinKyun Na; Jong-Sup Bae
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

8.  Orientin inhibits HMGB1-induced inflammatory responses in HUVECs and in murine polymicrobial sepsis.

Authors:  Hayoung Yoo; Sae-Kwang Ku; Taeho Lee; Jong-Sup Bae
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

10.  Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia.

Authors:  Li C Chen; Ronald E Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2007-09-14       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.